More pressure on Ottawa to move forward on legalization of psilocybin.

Lume Cannabis Company in Michigan has partnered with the Sault Ste. Marie Tribe of Chippewa Indians to open a new retail cannabis dispensary on tribal lands.

MindMed completes its Phase 1 study of its non-hallucinogenic formulation of ibogaine.

Numinus establishes a partnership with one of Canada’s largest addiction treatment organizations.

Looking for the best CBD-infused edibles?

Five new medical marijuana dispensaries are rolling into Texas.

Mydecine Innovations Group has been building momentum with a string of recent announcements.

Globally, over 1 billion people are substance abusers. The U.S. addiction treatment market is already a $35 billion per year industry. Psychedelic drugs may be the (better) answer.

The Food and Drug Administration (FDA) published draft guidance on developing cannabis-based drugs on Tuesday.

While pot and pornography boasted impressive fan bases before the pandemic, both industries have seen an increase in users.